FDA says no to AZ’s Fasenra for nasal polyp indication
Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
Autoimmune diseases are triggered when the immune system malfunctions and attacks the body’s own structures. Although there is not, as yet, any…
Summary : Madhya Pradesh stood high in the vaccination numbers for children between 15-18 years, for which the drive started from January…
Blueprint Medicines Corporation a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on…
Summary : – Expands Blueprint Medicines’ lung cancer pipeline with LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion…
Synopsis: Founded in 2018, Loop Health is a new age healthcare provider in India that combines high-quality primary care and insurance for…
KEYPOINTS: QIAGEN (QGEN) and DiaSorin said that the U.S. Food and Drug Administration has approved the LIAISON QuantiFERON-TB Gold Plus assay for…
SYNOPSIS: The UN health agency said the Covid strain first discovered in southern Africa was a “highly divergent variant with a high…
SYNOPSIS: Alembic Pharmaceuticals Limited announced that its joint venture Aleor Dermaceuticals Limited has received final approval from the US Food & Drug…
Abstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (Dapagliflozin) within…